NCT02853604: A trial that was reported late by Advaxis, Inc.
This trial has reported, although it was 929 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02853604 |
|---|---|
| Title | Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 15, 2015 |
| Completion date | July 31, 2019 |
| Required reporting date | July 30, 2020, midnight |
| Actual reporting date | Feb. 15, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 929 |